From Chronic Cerebral Hypoperfusion to Alzheimer-Like Brain Pathology and Neurodegeneration

Chronic cerebral hypoperfusion (CCH) is a common consequence of various cerebral vascular disorders and hemodynamic and blood changes. Recent studies have revealed an important role of CCH in neurodegeneration and dementia, including vascular dementia and Alzheimer’s disease (AD). This article revie...

Full description

Saved in:
Bibliographic Details
Published in:Cellular and molecular neurobiology 2015-01, Vol.35 (1), p.101-110
Main Authors: Zhao, Yang, Gong, Cheng-Xin
Format: Article
Language:English
Subjects:
Alzheimer Disease - pathology
Alzheimer Disease - physiopathology
Animals
Biomedical and Life Sciences
Biomedicine
Brain - blood supply
Brain - pathology
Cell Biology
Cerebrovascular Circulation - physiology
Humans
Neurobiology
Neurodegenerative Diseases - pathology
Neurodegenerative Diseases - physiopathology
Neurosciences
Review Paper
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chronic cerebral hypoperfusion (CCH) is a common consequence of various cerebral vascular disorders and hemodynamic and blood changes. Recent studies have revealed an important role of CCH in neurodegeneration and dementia, including vascular dementia and Alzheimer’s disease (AD). This article reviews the recent advances in understanding CCH-induced neurodegeneration and AD-related brain pathology and cognitive impairment. We discuss the causes and assessment of CCH, the possible mechanisms by which CCH promotes Alzheimer-like pathology and neurodegeneration, and animal models of CCH. It appears that CCH promotes neurodegeneration and AD through multiple mechanisms, including induction of oxidative stress, Aβ accumulation and aggravation, tau hyperphosphorylation, synaptic dysfunction, neuronal loss, white matter lesion, and neuroinflammation. Better understanding of the mechanisms of CCH will help develop therapeutic strategies for preventing and treating neurodegeneration, including sporadic AD and vascular dementia, caused by CCH.
ISSN:0272-4340
1573-6830
DOI:10.1007/s10571-014-0127-9